CorEvitas

NCT01402661

CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry

NCT01625650

Effectiveness Registry to Study Therapies for Arthritis and Inflammatory Conditions: The Corrona CERTAIN Sub-study

NCT01407419

The CORRONA Treat to Target Trial: Outcomes and Feasibility in a US Population

NCT02530268

The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) Registry

NCT02707341

The CorEvitas Psoriasis (PSO) Registry

NCT02737449

CorEvitas Japan Rheumatoid Arthritis (RA) Registry

NCT03162549

CorEvitas Inflammatory Bowel Disease (IBD) Registry

NCT03291756

CorEvitas Multiple Sclerosis (MS) Registry

NCT04512573

Patient Outcomes: Real World Evidence in Rheumatoid Arthritis (POWER)

NCT04504955

CorEvitas Atopic Dermatitis Registry: a Study of Post Approval Drug Safety and Effectiveness

NCT04899895

Rheumatology Biorepository

NCT04886492

CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT05762445

PAtient-CenTric Chronic Pancreatitis Registry (PACT-CP)

NCT05745389

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

NCT06354101

The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.

NCT06100991

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

NCT06238765

CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

NCT06562270

CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

NCT06521944

RSV Vaccine Pregnancy Registry

NCT06804057

CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

NCT06910553

IBD Pregnancy Registry

NCT07217509

PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry